Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA study

BACKGROUND: Safety data on disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) during breastfeeding are limited. OBJECTIVE: Assess safety outcomes for offspring breastfed by mothers undergoing glatiramer acetate (GA; Copaxone(®)) treatment. METHODS: This non-interventional, ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciplea, Andrea Ines, Kurzeja, Anna, Thiel, Sandra, Haben, Sabrina, Alexander, Jessica, Adamus, Evelyn, Hellwig, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315183/
https://www.ncbi.nlm.nih.gov/pubmed/35362346
http://dx.doi.org/10.1177/13524585221083982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315183/
https://www.ncbi.nlm.nih.gov/pubmed/35362346
http://dx.doi.org/10.1177/13524585221083982

Ejemplares similares